The Analysis of Muscle Relaxants by Mass Spectrometric Methods

  • Diane Rindgen
  • Paul Vouros
Chapter
Part of the Modern Analytical Chemistry book series (MOAC)

Abstract

The introduction of curare in 1942 (1) generated a great interest in the chemistry and pharmacology of a class of compounds known as neuromuscular blocking agents. Curare, a generic term for several South American arrow poisons, has enjoyed a long and romantic history (2). It has been used for many years by the Indians living in the regions surrounding the Amazon and Orinoco Rivers for killing wild animals for food. Only tribal witch doctors possessed the knowledge of the preparation of curare. Following the discovery of the American continent, early explorers became interested in this compound and brought samples of the native preparations to Europe for evaluation.

Keywords

Muscle Relaxant Chemical Ionization Fast Atom Bombardment Neuromuscular Blocking Agent Pancuronium Bromide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Griffith, H. R., and Johnson, G. E., 1942, The Use of Curare in General Anesthesia, Anesthesiology 3:418–420.CrossRefGoogle Scholar
  2. 2.
    Taylor, P., 1985, Neuromuscular Blocking Agents, in: The Pharmacological Basis of Therapeutics, 7th ed. (Gilman, A. G., Goodman, L. S., Rall, T. W., Murad, F., eds.), pp. 222–235. Macmillan, New York.Google Scholar
  3. 3.
    Miller, R. D., and Savarese, J. J., 1986, Pharmacology of Muscle Relaxants and Their Antagonists, in: Anesthesia, Vol. 2, 2nd ed. (Miller, R. D., ed.), pp. 889–943. Churchill Livingstone, New York.Google Scholar
  4. 4.
    Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D., 1989, Molecular Biology of the Cell, 2nd ed., pp. 319–321, Garland, New York.Google Scholar
  5. 5.
    Buckett, W. R., Marjoribanks, C. E. B., Marwick, F. A., and Morton, M. B., 1968, The Pharmacology of Pancuronium Bromide (Org.NA97), a New Potent Steroidal Neuromuscular Blocking Agent, Br. J. Pharmacol. Chemother. 32:671–682.CrossRefGoogle Scholar
  6. 6.
    Baird, W. L. M., and Reid, A. M., 1967, The Neuromuscular Blocking Properties of a New Steroid Compound, Pancuronium Bromide, Br. J. Anaesth. 39:775–780.CrossRefGoogle Scholar
  7. 7.
    Miller, R. D., Rupp, S. M., Fisher, D. M., Cronnelly, R., Fahey, M. R., and Sohn, Y. J., 1984, Clinical Pharmacology of Vecuronium and Atracurium, Anesthesiology 61:444–453.CrossRefGoogle Scholar
  8. 8.
    Miller, R. D., Agoston, S., Booij, L. H. D. J., Kersten, U. W., Crul, J. F., and Ham, J., 1978, The Comparative Potency and Pharmacokinetics of Pancuronium and Its Metabolites in Anesthetized Man, J. Pharmacol. Exp. Ther. 207:539–543.Google Scholar
  9. 9.
    Roth, S., and Ebrahim, Z. Y, 1987, Resistance to Pancuronium in Patients Receiving Carbamazepine, Anesthesiology, 66:691–693.CrossRefGoogle Scholar
  10. 10.
    Ornstein, E., Matteo, R. S, Schwartz, A. E., Silverburg, P. A., Young, W. L., and Diaz, J., 1987, The Effect of Phenytoin on the Magnitude and Duration of Neuromuscular Block Following Atracurium or Vecuronium, Anesthesiology, 67:191–196.CrossRefGoogle Scholar
  11. 11.
    Martyn, J. A. J., Goldhill, D. R., and Goudsouzian, N. G., 1986, Clinical Pharmacology of Muscle Relaxants in Patients with Burns, J. Clin. Pharmacol. 26:680–685.CrossRefGoogle Scholar
  12. 12.
    Kersten, U. W., Meijer, D. K. F., and Agoston, S., 1973, Fluorimetric and Chromatographic Determination of Pancuronium Bromide and Its Metabolites in Biological Materials, Clin. Chim. Acta 44:59–66.CrossRefGoogle Scholar
  13. 13.
    Tanaka, K., Hioki, M., and Shindo, H., 1974, Determination of Pancuronium Bromide and Its Metabolites in Human Urine by Dye-Extraction Method—Relation between the Extractability and Structure of Quaternary Ammonium Ions, Chem. Pharm. Bull. 22(11):2599–2606.CrossRefGoogle Scholar
  14. 14.
    Buzello, W., 1974, The Colorimetric Determination of Pancuronium and Its Desacetyl Derivatives in the Human Body Fluids, Anaesthesist 23:443–449.Google Scholar
  15. 15.
    Kinget, R, D., and Michoel, A. J., 1976, Thin-Layer Chromatography of Pancuronium Bromide and Its Hydrolysis Products, J. Chromatogr. 120:234–238.CrossRefGoogle Scholar
  16. 16.
    Paanakker, J. E., and Van de Laar, G. L. M., 1980, Determination of Org NC45 (A Myoneural Blocking Agent) in Human Plasma Using High-Performance Normal-Phase Liquid Chromatography, J. Chromatogr. 183:459–466.Google Scholar
  17. 17.
    Furuta, T., Canfell, P. C., Castagnoli, K. P., Sharma, M. L., and Miller, R. D., 1988, Quantitation of Pancuronium, S-Desacetylpancuronium, Vecuronium, 3-Desacetylvecuronium, Pipecuronium and 3-Desacetylpipecuronium in Biological Fluids by Capillary Gas Chromatography Using Nitrogen-Sensitive Detection, J. Chromatogr. 427:41–53.Google Scholar
  18. 18.
    Segredo, V, Matthay, M. A., Sharma, M. L., Gruenke, L. D., Caldwell, J. E., and Miller, R. D., 1990, Prolonged Neuromuscular Blockade after Long-Term Administration of Vecuronium in Two Critically Ill Patients, Anesthesiology 72:566–570.CrossRefGoogle Scholar
  19. 19.
    Agoston, S., 1991, Paralysis after Long-Term Administration of Vecuronium, Anesthesiology 74:792–793.CrossRefGoogle Scholar
  20. 20.
    Segredo, V, and Sharma, M., 1991, [A Reply to S. Agoston.] Anesthesiology 74:793–794.CrossRefGoogle Scholar
  21. 21.
    Horowitz, P. E., and Spector, S., 1973, Determination of Serum d-Tubocurarine Concentration by Radioimmunoassay, J. Pharmacol. Exp. Ther. 185:94–100.Google Scholar
  22. 22.
    Annan, R. S., Kim, C., and Martyn, J. A. J., 1990, Measurement of d-Tubocurarine Chloride in Human Urine Using Solid-Phase Extraction and Reversed-Phase High-Performance Liquid Chromatography with Ultraviolet Detection, J. Chromatogr. 526:228–234.Google Scholar
  23. 23.
    Baker, T. R., Vouros, P., and Martyn, J. A. J., 1989, Mass Spectrometry of Pancuronium Bromide and Related Quaternary Ammonium Steroids Using the Moving Belt LC/MS Interface, Org. Mass Spectrom. 24:723–732.CrossRefGoogle Scholar
  24. 24.
    Baker, T. R., Vouros, P., and Martyn, J. A. J., 1990, Mass Spectrometry of Various Neuromuscular Blocking Agents, Org. Mass Spectrom. 25:131–134.CrossRefGoogle Scholar
  25. 25.
    Longevialle, P., Milne, G. W., and Fales, H. M., 1973, Chemical Ionization Mass Spectrometry of Complex Molecules. XL Stereochemical and Conformational Effects in the Isobutane Chemical Ionization Mass Spectra of Some Steroidal Amino Alcohols, J. Am. Chem. Soc. 95:6666–6669.CrossRefGoogle Scholar
  26. 26.
    Wilson, M. S., and McCloskey, J. A., 1975, Chemical Ionization Mass Spectrometry of Nucleosides. Mechanisms of Ion Formation and Estimations of Proton Affinity, J. Am. Chem. Soc. 97:3436–3444.CrossRefGoogle Scholar
  27. 27.
    Dzidic, I., and McCloskey, J. A., 1971, Influence of Remote Functional Groups in the Chemical Ionization Mass Spectra of Long-Chain Compounds, J. Am. Chem. Soc. 93:4955–4956.CrossRefGoogle Scholar
  28. 28.
    Weinkam, R. J., 1974, The Importance of Intramolecular Associations in the Chemical Ionization Mass Spectra of Monoenoic and Monoepoxy Fatty Acid Methyl Esters, J. Am. Chem. Soc. 96:1032–1037.CrossRefGoogle Scholar
  29. 29.
    Castagnoli, K. P., Shinohara, Y., Furuta, T., Nguyen, T. L., Gruenke, L. D., Miller, R. D, and Castagnoli, N., 1986, Quantitative Estimation of Quaternary Ammonium Neuromuscular Blocking Agents in Serum by Direct Insertion Probe Chemical Ionization Mass Spectrometry, Biomed. Environ, Mass Spectrom. 13:327–332.CrossRefGoogle Scholar
  30. 30.
    Baker, T. R., Vouros, P., Rindgen, D., and Martyn, J. A. J., 1990, Mass Spectrometric Assay for Determination of Pancuronium and Vecuronium in Biological Fluids Utilizing the Moving Belt Introduction System, Biomed. Environ. Mass Spectrom. 19:69–74.CrossRefGoogle Scholar
  31. 31.
    Schubert, R., Schroeder, E., and Jacobs, P., 1988, Applications of Continuous Flow FAB Mass Spectrometry for the Study of Drug Metabolism, Proceedings of the 36th ASMS Conference on Mass Spectrometry and Allied Topics, San Francisco, CA, June 5–10, 1988, pp. 151-152.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Diane Rindgen
    • 1
  • Paul Vouros
    • 1
  1. 1.Department of Chemistry and The Barnett Institute of Chemical Analysis and Materials ScienceNortheastern UniversityBostonUSA

Personalised recommendations